BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 2429439)

  • 1. Derivation of neutralizing monoclonal antibodies to human rotaviruses and evidence that an immunodominant neutralization site is shared between serotypes 1 and 3.
    Coulson BS; Tursi JM; McAdam WJ; Bishop RF
    Virology; 1986 Oct; 154(2):302-12. PubMed ID: 2429439
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preparation and characterization of neutralizing monoclonal antibodies with different reactivity patterns to human rotaviruses.
    Taniguchi K; Urasawa S; Urasawa T
    J Gen Virol; 1985 May; 66 ( Pt 5)():1045-53. PubMed ID: 2987395
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neutralizing monoclonal antibodies to human rotavirus and indications of antigenic drift among strains from neonates.
    Coulson BS; Fowler KJ; Bishop RF; Cotton RG
    J Virol; 1985 Apr; 54(1):14-20. PubMed ID: 2579249
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neutralizing monoclonal antibodies against three serotypes of porcine rotavirus.
    Nagesha HS; Brown LE; Holmes IH
    J Virol; 1989 Aug; 63(8):3545-9. PubMed ID: 2545925
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Variation in neutralization epitopes of human rotaviruses in relation to genomic RNA polymorphism.
    Coulson BS
    Virology; 1987 Aug; 159(2):209-16. PubMed ID: 2441519
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Direct serotyping of human rotavirus in stools by an enzyme-linked immunosorbent assay using serotype 1-, 2-, 3-, and 4-specific monoclonal antibodies to VP7.
    Taniguchi K; Urasawa T; Morita Y; Greenberg HB; Urasawa S
    J Infect Dis; 1987 Jun; 155(6):1159-66. PubMed ID: 3033090
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Operational overlapping of cross-reactive and serotype-specific neutralization epitopes on VP7 of human rotavirus serotype 3.
    Kobayashi N; Taniguchi K; Urasawa S
    Arch Virol; 1991; 117(1-2):73-84. PubMed ID: 1706592
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Determination of rotavirus serotype-specific antibodies in sera by competitive enhanced enzyme immunoassay.
    Beards GM; Desselberger U
    J Virol Methods; 1989; 24(1-2):103-10. PubMed ID: 2547808
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cross-reactive, serotype- and monotype-specific neutralization epitopes on VP7 of serotype G3 and G5 porcine rotavirus strains.
    Ciarlet M; Hidalgo M; Liprandi F
    Arch Virol; 1996; 141(3-4):601-14. PubMed ID: 8645098
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of a monoclonal antibody specific for serotype 3 rotavirus strains.
    Grunert B; Streckert HJ; Liedtke W; Houly C; Mietens C; Werchau H
    Eur J Clin Microbiol; 1987 Apr; 6(2):136-41. PubMed ID: 3036497
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of serotype-specific neutralization epitopes on VP7 of human rotavirus by the use of neutralizing monoclonal antibodies and antigenic variants.
    Morita Y; Taniguchi K; Urasawa T; Urasawa S
    J Gen Virol; 1988 Feb; 69 ( Pt 2)():451-8. PubMed ID: 2448418
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of cross-reactive and serotype 2-specific neutralization epitopes on VP3 of human rotavirus.
    Taniguchi K; Maloy WL; Nishikawa K; Green KY; Hoshino Y; Urasawa S; Kapikian AZ; Chanock RM; Gorziglia M
    J Virol; 1988 Jul; 62(7):2421-6. PubMed ID: 2453680
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An equine rotavirus (FI-14 strain) which bears both subgroup I and subgroup II specificities on its VP6.
    Hoshino Y; Gorziglia M; Valdesuso J; Askaa J; Glass RI; Kapikian AZ
    Virology; 1987 Apr; 157(2):488-96. PubMed ID: 2435059
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preparation and characterization of a neutralizing monoclonal antibody directed to VP4 of rotavirus strain K8 which has unique VP4 neutralization epitopes.
    Kobayashi N; Taniguchi K; Urasawa T; Urasawa S
    Arch Virol; 1991; 121(1-4):153-62. PubMed ID: 1722090
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reactivities of serotyping monoclonal antibodies with culture-adapted human rotaviruses.
    Ward RL; McNeal MM; Clemens JD; Sack DA; Rao M; Huda N; Green KY; Kapikian AZ; Coulson BS; Bishop RF
    J Clin Microbiol; 1991 Mar; 29(3):449-56. PubMed ID: 1709945
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antigenic analysis of rotavirus isolates using monoclonal antibodies specific for human serotypes 1, 2, 3 and 4, and SA11.
    Heath R; Birch C; Gust I
    J Gen Virol; 1986 Nov; 67 ( Pt 11)():2455-66. PubMed ID: 3023533
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human rotavirus VP4 contains strain-specific, serotype-specific and cross-reactive neutralization sites.
    Kirkwood CD; Bishop RF; Coulson BS
    Arch Virol; 1996; 141(3-4):587-600. PubMed ID: 8645097
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Independent segregation of two antigenic specificities (VP3 and VP7) involved in neutralization of rotavirus infectivity.
    Hoshino Y; Sereno MM; Midthun K; Flores J; Kapikian AZ; Chanock RM
    Proc Natl Acad Sci U S A; 1985 Dec; 82(24):8701-4. PubMed ID: 3001716
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis by plaque reduction neutralization assay of intertypic rotaviruses suggests that gene reassortment occurs in vivo.
    Hoshino Y; Sereno MM; Midthun K; Flores J; Chanock RM; Kapikian AZ
    J Clin Microbiol; 1987 Feb; 25(2):290-4. PubMed ID: 2434522
    [TBL] [Abstract][Full Text] [Related]  

  • 20. VP4 and VP7 typing using monoclonal antibodies.
    Coulson BS
    Arch Virol Suppl; 1996; 12():113-8. PubMed ID: 9015108
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.